Spectroscopy of blood plasma has the potential to differentiate metabolic dysfunction-associated steatohepatitis from steatosis

被引：0

作者：

Novakova, Barbora ^{[1
,2
,3
,4
]}

Vrtelka, Ondrej ^{[5
]}

Kralova, Katerina ^{[5
]}

Zizalova, Katerina ^{[6
,7
]}

Smid, Vaclav ^{[1
,2
]}

Dvorak, Karel ^{[6
,7
,8
]}

Petrtyl, Jaromir

Vitek, Libor ^{[1
,2
,6
,7
]}

Lenicek, Martin ^{[6
,7
]}

Setnicka, Vladimir ^{[5
]}

Bruha, Radan ^{[1
,2
]}

机构：

[1] Charles Univ Prague, Dept Internal Med 4, Fac Med 1, Prague 12808, Czech Republic

[2] Charles Univ Prague, Gen Univ Hosp, Prague 12808, Czech Republic

[3] Charles Univ Prague, Inst Med Biochem & Lab Diagnost, Fac Med 1, Prague 12108, Czech Republic

[4] Charles Univ Prague, Gen Univ Hosp Prague, Prague 12108, Czech Republic

[5] Univ Chem & Technol Prague, Dept Analyt Chem, Tech 5, Prague 16628 6, Czech Republic

[6] Charles Univ Prague, Inst Med Biochem & Lab Diagnost, Fac Med 1, Prague 12108, Czech Republic

[7] Charles Univ Prague, Gen Univ Hosp Prague, Prague 12108, Czech Republic

[8] Reg Hosp Liberec, Liberec 46001, Czech Republic

来源：

JOURNAL OF HEPATOLOGY | 2024年 / 80卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

WED-280

引用

页码：S539 / S540

页数：2

共 50 条

[1] A Pragmatic Management Approach for Metabolic Dysfunction-Associated Steatosis and Steatohepatitis
Shah, Neha
Sanyal, Arun J.
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2025, 120 (01): : 75 - 82
[2] Epigenetics in metabolic dysfunction-associated steatohepatitis
Zhang, Yanru
Ding, Ruike
Hu, Liangshuo
Liu, Enqi
Qu, Pengxiang
CELLULAR SIGNALLING, 2025, 130
[3] Denifanstat for the treatment of metabolic dysfunction-associated steatohepatitis
Li, Xincheng
Ayada, Ibrahim
Li, Pengfei
Pan, Qiuwei
LANCET GASTROENTEROLOGY & HEPATOLOGY, 2025, 10 (02): : 108 - 109
[4] Expanding the armamentarium for metabolic dysfunction-associated steatohepatitis
Francque, Sven M.
Vonghia, Luisa
LANCET GASTROENTEROLOGY & HEPATOLOGY, 2024, 9 (12): : 1066 - 1067
[5] Resmetirom (Rezdiffra) for Metabolic Dysfunction-Associated Steatohepatitis
不详
MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2024, 66 (1701):
[6] Prediction of metabolic dysfunction-associated steatohepatitis resolution
Loomba, Rohit
Amangurbanova, Maral
Bettencourt, Ricki
Madamba, Egbert
Siddiqi, Harris
Richards, Lisa
Gottwald, Mildred D.
Feng, Shibao
Margalit, Maya
Huang, Daniel
JOURNAL OF HEPATOLOGY, 2024, 80 : S522 - S523
[7] Cardiovascular Risk Reduction in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis
Bernhard, Johannes
Galli, Lukas
Speidl, Walter S.
Krychtiuk, Konstantin A.
CURRENT CARDIOLOGY REPORTS, 2025, 27 (01)
[8] Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis: The Patient and Physician Perspective
Eskridge, Wayne
Cryer, Donna R.
Schattenberg, Joern M.
Gastaldelli, Amalia
Malhi, Harmeet
Allen, Alina M.
Noureddin, Mazen
Sanyal, Arun J.
JOURNAL OF CLINICAL MEDICINE, 2023, 12 (19)
[9] Metabolic dysfunction-associated steatohepatitis (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) require urgent attention by primary care physicians and endocrinologists
Mauricio, Didac
Escalada, Javier
Perez, Antonio
Romero-Gomez, Manuel
Cusi, Kenneth
Younoussi, Zobair M.
Lazarus, Jeffrey V.
ENDOCRINOLOGIA DIABETES Y NUTRICION, 2024, 71 (04): : 149 - 151
[10] Targeting macrophage BTK, a potential therapeutic strategy for metabolic dysfunction-associated steatohepatitis
Chen, Shiwei
Zhou, Cheng
Wang, Yanbo
Lou, Guohua
Zheng, Min
JOURNAL OF HEPATOLOGY, 2024, 80 : S586 - S586

← 1 2 3 4 5 →